What is the latest MEDIORG stock price?
The latest stored price for MEDIORG is Rs 21.65 as of 2026-09-18.
gimli
MEDIORG stock AI analysis
MEDIORG Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
MEDICAMEN ORGANICS LTD is a small-cap stock in Unclassified. This Gimli page shows the latest available MEDIORG price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹21.65
1W return
-14.09%
1M return
-10.91%
3M return
-3.99%
6M return
-10.72%
1Y return
-39.36%
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
-13.61%
ROCE
-10.67%
RSI
39.70
Turnover
₹0.00 cr
Why it can matter in screens
- Momentum: MEDIORG is below 50DMA, below 200DMA; RSI is 39.70.
- Returns: 1D -4.84%, 1W -14.09%, 1M -10.91%, 3M -3.99%, 1Y -39.36%.
- Trend levels: 52W high ₹38.00, 52W low ₹19.10, off high -43.03%.
- Liquidity: latest turnover is ₹0.00 cr; volume vs 20D is +0.19%.
- Valuation/profitability: PE n/a, PB n/a, ROE -13.61%, ROCE -10.67%.
- Growth: 3Y sales CAGR +0.72%, 3Y profit CAGR n/a.
Quick Answers
Is MEDIORG above its 50DMA and 200DMA?
MEDIORG is below 50DMA, below 200DMA. The latest 50DMA is 24.57 and the latest 200DMA is 25.74.
What are MEDIORG PE, ROE and ROCE?
MEDIORG has PE n/a, ROE -13.61%, and ROCE -10.67% in Gimli's latest available snapshot.
How has MEDIORG performed recently?
MEDIORG has returned -10.91% over 1 month, -3.99% over 3 months, and -39.36% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 22.63 cr | -3.67 cr | -4.02 cr | nan |
| 2025-03-31 | 38.19 cr | 6.68 cr | 4.05 cr | 3.67 |
| 2024-03-31 | 25.27 cr | 5.78 cr | 2.62 cr | 2.24 |
| 2023-03-31 | 22.15 cr | 2.64 cr | 0.97 cr | 0.83 |
| 2022-03-31 | n/a | n/a | n/a | 0.09 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 51.63 cr | 1.30 cr | 14.29 cr | 28.59 cr |
| 2025-03-31 | 59.21 cr | 4.13 cr | 12.35 cr | 30.48 cr |
| 2024-03-31 | 38.44 cr | 0.55 cr | 12.66 cr | 15.26 cr |
| 2023-03-31 | 32.59 cr | 0.53 cr | 11.79 cr | 8.98 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | -4.60 cr | -6.33 cr | n/a |
| 2025-03-31 | -4.54 cr | -6.99 cr | n/a |
| 2024-03-31 | -3.66 cr | -4.01 cr | n/a |
| 2023-03-31 | -0.58 cr | -0.87 cr | n/a |
| 2022-03-31 | n/a | n/a | n/a |
Shareholding Trend
No recent data available.
Industry Peers
No recent data available.
Try these prompts
- Analyze MEDICAMEN ORGANICS with valuation, momentum and industry peers
- Compare MEDIORG with other Unclassified stocks
- Show small-cap stocks in Unclassified above 50DMA with positive 1M return
- Find Unclassified stocks with improving momentum and reasonable valuation
Related screen ideas
- View Unclassified stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare MEDIORG with other Unclassified stocks
Data snapshot: 2026-09-18. Not investment advice.